Recent peer-reviewed studies are strengthening the case for a link between cellphone radiation and brain cancer, despite prior findings from the World Health Organization (WHO) that suggested no substantial evidence of harm. South Korean researchers, in an analysis of 24 studies published in Environmental Health, identified a higher risk of malignant brain tumors, such as meningioma and glioma, in individuals who frequently use cellphones, especially on the side of the head where they hold their devices.
This South Korean study adds to seven other meta-analyses since 2016 that associate cellphone radiation with increased brain cancer risks, as noted by Joel Moskowitz, Ph.D., director of the Center for Family and Community Health at the University of California, Berkeley. Moskowitz has been an active researcher in the public health implications of wireless technology for over a decade. He suggests that these studies stand in stark opposition to the conclusions of the WHO’s recent review, raising concerns that industry biases might have influenced the global organization’s findings.
Miriam Eckenfels-Garcia, who directs the Children’s Health Defense’s (CHD) Electromagnetic Radiation and Wireless program, emphasized the need for WHO to reconsider its stance, despite anticipated challenges. She cautions that the WHO’s dismissal of non-industry-funded research as “misinformation” could inadvertently place the public at greater risk.
Lennart Hardell, M.D., Ph.D., a leading expert on wireless radiation’s impact on health, echoed these concerns, noting the discrepancy between WHO’s report and recent findings. Hardell, who has conducted extensive research on cellphone use and cancer, attributes WHO’s conclusions to what he describes as “fraudulent behavior” that undermines public health and scientific integrity. He asserts that this lack of ethical transparency gives the green light to further implement potentially hazardous technologies, leaving the general population uninformed and at risk.
Brain Tumor Rates on the Rise in Denmark and Beyond
The South Korean study comes on the heels of new findings in Denmark, which show a concerning increase in central nervous system tumors, including brain cancers. Denmark’s well-regarded cancer tracking system has revealed a noticeable rise in such cancers, with tumors of the central nervous system among the fastest-growing cancer types over the past decade, especially from 2014 to 2023. These statistics challenge the assumption that brain tumor rates remain stable, a point previously used to downplay any connection between cellphone use and cancer.
A recent global study on brain cancer from 1990 to 2019 highlights an increase in brain cancer diagnoses, predominantly in Western countries. Although the National Cancer Institute reports that the U.S. hasn’t seen a rise in overall brain and nervous system cancer rates, Joel Moskowitz and other researchers warn that these rates may not fully capture the reality. Factors such as underreporting or regional variations could obscure the actual incidence of brain tumors, especially more aggressive forms like glioblastoma.
Related news: Exposed: Big Pharma’s $1 Billion Payouts to Journal Reviewers—What It Means for Medical Integrity
Ellie Marks, co-founder of the California Brain Tumor Association, has a personal connection to the issue: her husband was diagnosed with a brain tumor that experts have attributed to his long-term cellphone use. Following his diagnosis in 2008, Marks sought the opinions of specialists, including Hardell, who identified her husband’s case as a clear example of cellphone-related cancer risk. Marks emphasizes that her husband’s experience is far from unique, and that many others face similar health challenges linked to cellphone use.
FDA Overlooks Cellphone Radiation Research Amid Mounting Evidence
Despite rising brain cancer concerns, the U.S. Food and Drug Administration (FDA) maintains there is insufficient evidence to associate cellphone radiation with health risks, including brain cancer. The FDA even disregarded findings from a significant $30 million National Toxicology Program (NTP) study it had commissioned. This multi-year study found “clear evidence” that male rats exposed to high levels of wireless radiation developed cancerous tumors in the heart, with additional evidence of brain and adrenal tumors in male rats. However, the FDA dismissed these results and later released a critical review of the study in 2020.
In response to the apparent surge in brain tumors, Eckenfels-Garcia argues that this issue exemplifies the consequences of governmental agencies disregarding scientific evidence, as she observed with the FDA’s handling of the NTP study. Moskowitz adds that the FDA’s lack of follow-up on the NTP’s findings highlights a broader failure to address the potential health risks of wireless radiation. The National Institutes of Health (NIH) has also faced scrutiny for halting further research on this topic; the CHD has since filed a Freedom of Information Act request for documents detailing the NIH’s decision to stop the NTP’s work, but the agency has yet to respond.
In light of these ongoing developments, researchers and advocates stress the need for comprehensive and unbiased studies on cellphone radiation. The potential public health implications of these findings underscore the urgency of transparent research and clear communication regarding the possible risks associated with prolonged cellphone use.
See also: New Findings Reveal Undeclared Heavy Metals and Chemicals in COVID-19 Vaccines
